KDNY
Chinook Therapeutics, Inc. Common Stock
KDNY
KDNY
Delisted
KDNY was delisted on the 10th of August, 2023.
103 hedge funds and large institutions have $707M invested in Chinook Therapeutics, Inc. Common Stock in 2021 Q4 according to their latest regulatory filings, with 25 funds opening new positions, 50 increasing their positions, 17 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
21% more funds holding
Funds holding: 85 → 103 (+18)
2% more call options, than puts
Call options by funds: $47K | Put options by funds: $46K
Holders
103
Holding in Top 10
4
Calls
$47K
Puts
$46K
Top Buyers
| 1 | +$29.4M | |
| 2 | +$22.1M | |
| 3 | +$20.9M | |
| 4 |
SB
Samsara BioCapital
Palo Alto,
California
|
+$19.8M |
| 5 |
RCM
RA Capital Management
Boston,
Massachusetts
|
+$16.3M |
Top Sellers
| 1 | -$5.12M | |
| 2 | -$3.07M | |
| 3 | -$2.66M | |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$2.28M |
| 5 |
Two Sigma Investments
New York
|
-$1.84M |